The authors suggest that venous thrombosis may be more directly influenced by inflammation and obesity-related hypercoagulability, which could make it more responsive to GLP-1 therapy, Yi continued
With the patent for the drug set to expire in January 2026 in Canada, the market is likely to see a surge in generic offerings, which could lead to a significant increase in the number of individuals using GLP-1 medications
Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome
10.1007/s12325-012-0045-5 35
Follow with a broad-spectrum sunscreen to reduce the risk of sun damage
Consistently, in a rat model of MIinduced heart failure, exendin-4 decreased susceptibility to atrial arrhythmogenesis, improved conduction properties, and attenuated atrial fibrosis [33]